Synopsis
Synopsis
0
CEP/COS
0
JDMF
0
EU WC
0
KDMF
0
NDC API
0
VMF
0
Listed Suppliers
0
EDQM
0
USP
0
JP
0
Others
0
Europe
0
Canada
0
Australia
0
South Africa
0
Listed Dossiers
DRUG PRODUCT COMPOSITIONS
0
US Patents
0
US Exclusivities
0
Health Canada Patents
US Medicaid
NA
Annual Reports
NA
Regulatory FDF Prices
NA
0
API
0
FDF
0
Data Compilation #PharmaFlow
0
Stock Recap #PipelineProspector
0
Weekly News Recap #Phispers
0
News #PharmaBuzz
1. Org 9487
2. Org-9487
3. Rapacuronium
4. Raplon
1. Raplon
2. 156137-99-4
3. Org 9487
4. Org-9487
5. 156137-99-4 (bromide)
6. 65q4qdg4kc
7. 1-((2s,3s,5s,8r,9s,10s,13s,14s,16s,17r)-3-acetoxy-10,13-dimethyl-2-(piperidin-1-yl)-17-(propionyloxy)hexadecahydro-1h-cyclopenta[a]phenanthren-16-yl)-1-allylpiperidin-1-ium Bromide
8. Raplon (tn)
9. Ncgc00183839-01
10. Unii-65q4qdg4kc
11. Rapacuronium Bromide [usan:inn:ban]
12. Dsstox_cid_28749
13. Dsstox_rid_83018
14. Dsstox_gsid_48823
15. Schembl41132
16. 1-(3alpha-acetoxy-2beta-(1-piperidinyl)-17beta-(propionyloxy)-5alpha-androsta-16beta-yl)-1-allylpiperidinium Bromide
17. Chembl1200549
18. Dtxsid7048823
19. Rapacuronium Bromide [mi]
20. Rapacuronium Bromide (usan/inn)
21. Rapacuronium Bromide [inn]
22. Rapacuronium Bromide [usan]
23. Rapacuronium Bromide [vandf]
24. Tox21_113304
25. Rapacuronium Bromide [mart.]
26. Rapacuronium Bromide [who-dd]
27. Cs-6564
28. 1-allyl-1-(3alpha,17beta-dihydroxy-2beta-piperidino-5alpha-androstan-16beta-yl)piperidinium Bromide, 3-acetate 17-propionate
29. Hy-16423
30. Piperidinium, 1-((2beta,3alpha,5alpha,16beta,17beta)-3-(acetyloxy)-17-(1-oxopropoxy)-2-(1-piperidinyl)androstan-16-yl)-1-(2-propenyl)-, Bromide
31. Rapacuronium Bromide [orange Book]
32. Cas-156137-99-4
33. D05703
34. Q3419354
35. [(2s,3s,5s,8r,9s,10s,13s,14s,16s,17r)-3-acetyloxy-10,13-dimethyl-2-piperidin-1-yl-16-(1-prop-2-enylpiperidin-1-ium-1-yl)-2,3,4,5,6,7,8,9,11,12,14,15,16,17-tetradecahydro-1h-cyclopenta[a]phenanthren-17-yl] Propanoate;bromide
36. 1-allyl-1-(3.alpha.,17.beta.-dihydroxy-2.beta.-piperidino-5.alpha.-androstan-16.beta.-yl)piperidinium Bromide, 3-acetate 17-propionate
| Molecular Weight | 677.8 g/mol |
|---|---|
| Molecular Formula | C37H61BrN2O4 |
| Hydrogen Bond Donor Count | 0 |
| Hydrogen Bond Acceptor Count | 6 |
| Rotatable Bond Count | 9 |
| Exact Mass | 676.38147 g/mol |
| Monoisotopic Mass | 676.38147 g/mol |
| Topological Polar Surface Area | 55.8 Ų |
| Heavy Atom Count | 44 |
| Formal Charge | 0 |
| Complexity | 1030 |
| Isotope Atom Count | 0 |
| Defined Atom Stereocenter Count | 10 |
| Undefined Atom Stereocenter Count | 0 |
| Defined Bond Stereocenter Count | 0 |
| Undefined Bond Stereocenter Count | 0 |
| Covalently Bonded Unit Count | 2 |
Neuromuscular Nondepolarizing Agents
Drugs that interrupt transmission at the skeletal neuromuscular junction without causing depolarization of the motor end plate. They prevent acetylcholine from triggering muscle contraction and are used as muscle relaxants during electroshock treatments, in convulsive states, and as anesthesia adjuvants. (See all compounds classified as Neuromuscular Nondepolarizing Agents.)
ABOUT THIS PAGE
47
PharmaCompass offers a list of Rapacuronium API manufacturers, exporters & distributors, which can be sorted by GMP, USDMF, JDMF, KDMF, CEP (COS), WC, Price,and more, enabling you to easily find the right Rapacuronium manufacturer or Rapacuronium supplier for your needs.
Send us enquiries for free, and we will assist you in establishing a direct connection with your preferred Rapacuronium manufacturer or Rapacuronium supplier.
PharmaCompass also assists you with knowing the Rapacuronium API Price utilized in the formulation of products. Rapacuronium API Price is not always fixed or binding as the Rapacuronium Price is obtained through a variety of data sources. The Rapacuronium Price can also vary due to multiple factors, including market conditions, regulatory modifications, or negotiated pricing deals.
A Raplon manufacturer is defined as any person or entity involved in the manufacture, preparation, processing, compounding or propagation of Raplon, including repackagers and relabelers. The FDA regulates Raplon manufacturers to ensure that their products comply with relevant laws and regulations and are safe and effective to use. Raplon API Manufacturers are required to adhere to Good Manufacturing Practices (GMP) to ensure that their products are consistently manufactured to meet established quality criteria.
A Raplon supplier is an individual or a company that provides Raplon active pharmaceutical ingredient (API) or Raplon finished formulations upon request. The Raplon suppliers may include Raplon API manufacturers, exporters, distributors and traders.
click here to find a list of Raplon suppliers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PharmaCompass.
A Raplon DMF (Drug Master File) is a document detailing the whole manufacturing process of Raplon active pharmaceutical ingredient (API) in detail. Different forms of Raplon DMFs exist exist since differing nations have different regulations, such as Raplon USDMF, ASMF (EDMF), JDMF, CDMF, etc.
A Raplon DMF submitted to regulatory agencies in the US is known as a USDMF. Raplon USDMF includes data on Raplon's chemical properties, information on the facilities and procedures used, and details about packaging and storage. The Raplon USDMF is kept confidential to protect the manufacturer’s intellectual property.
click here to find a list of Raplon suppliers with USDMF on PharmaCompass.
Raplon Active pharmaceutical ingredient (API) is produced in GMP-certified manufacturing facility.
GMP stands for Good Manufacturing Practices, which is a system used in the pharmaceutical industry to make sure that goods are regularly produced and monitored in accordance with quality standards. The FDA’s current Good Manufacturing Practices requirements are referred to as cGMP or current GMP which indicates that the company follows the most recent GMP specifications. The World Health Organization (WHO) has its own set of GMP guidelines, called the WHO GMP. Different countries can also set their own guidelines for GMP like China (Chinese GMP) or the EU (EU GMP).
PharmaCompass offers a list of Raplon GMP manufacturers, exporters & distributors, which can be sorted by USDMF, JDMF, KDMF, CEP (COS), WC, API price, and more, enabling you to easily find the right Raplon GMP manufacturer or Raplon GMP API supplier for your needs.
A Raplon CoA (Certificate of Analysis) is a formal document that attests to Raplon's compliance with Raplon specifications and serves as a tool for batch-level quality control.
Raplon CoA mostly includes findings from lab analyses of a specific batch. For each Raplon CoA document that a company creates, the USFDA specifies specific requirements, such as supplier information, material identification, transportation data, evidence of conformity and signature data.
Raplon may be tested according to a variety of international standards, such as European Pharmacopoeia (Raplon EP), Raplon JP (Japanese Pharmacopeia) and the US Pharmacopoeia (Raplon USP).
